STAP1 and central nervous system cancer: Furthermore, we used the TCGA and CGGA public datasets and then divided patients with glioma into a low-STAP1 group and a high-STAP1 group according to the median mRNA levels of STAP1. The inclusion criteria and exclusion criteria were listed in Fig. S3.